Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes.

Literature DB >> 29312674

Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes.

Hamid Moradi^1,2, Elani Streja^1,2, Kamyar Kalantar-Zadeh^1,2.

Abstract

Entities: Chemical

Year: 2017 PMID： 29312674 PMCID： PMC5756987 DOI： 10.21037/jtd.2017.10.155

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 3.005

× No keyword cloud information.

22 in total

1. High-density lipoprotein cholesterol in diabetes: is higher always better?

Authors: Tina Costacou; Rhobert W Evans; Trevor J Orchard
Journal: J Clin Lipidol Date: 2011-06-28 Impact factor: 4.766

2. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Authors: Hamid Moradi; Elani Streja; Moti L Kashyap; Nosratola D Vaziri; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal: Nephrol Dial Transplant Date: 2014-02-25 Impact factor: 5.992

Review 3. High-density lipoprotein--the clinical implications of recent studies.

Authors: D J Gordon; B M Rifkind
Journal: N Engl J Med Date: 1989-11-09 Impact factor: 91.245

4. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.

Authors: Suguru Yamamoto; Patricia G Yancey; T Alp Ikizler; W Gray Jerome; Ryohei Kaseda; Brian Cox; Aihua Bian; Ayumi Shintani; Agnes B Fogo; Macrae F Linton; Sergio Fazio; Valentina Kon
Journal: J Am Coll Cardiol Date: 2012-11-07 Impact factor: 24.094

5. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors: William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal: N Engl J Med Date: 2011-11-15 Impact factor: 91.245

6. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Authors: Paolo Zanoni; Sumeet A Khetarpal; Daniel B Larach; William F Hancock-Cerutti; John S Millar; Marina Cuchel; Stephanie DerOhannessian; Anatol Kontush; Praveen Surendran; Danish Saleheen; Stella Trompet; J Wouter Jukema; Anton De Craen; Panos Deloukas; Naveed Sattar; Ian Ford; Chris Packard; Abdullah al Shafi Majumder; Dewan S Alam; Emanuele Di Angelantonio; Goncalo Abecasis; Rajiv Chowdhury; Jeanette Erdmann; Børge G Nordestgaard; Sune F Nielsen; Anne Tybjærg-Hansen; Ruth Frikke Schmidt; Kari Kuulasmaa; Dajiang J Liu; Markus Perola; Stefan Blankenberg; Veikko Salomaa; Satu Männistö; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Martina Müller-Nurasyid; Marco Ferrario; Frank Kee; Cristen J Willer; Nilesh Samani; Heribert Schunkert; Adam S Butterworth; Joanna M M Howson; Gina M Peloso; Nathan O Stitziel; John Danesh; Sekar Kathiresan; Daniel J Rader
Journal: Science Date: 2016-03-11 Impact factor: 47.728

7. Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression.

Authors: Samar R El Khoudary; Lin Wang; Maria M Brooks; Rebecca C Thurston; Carol A Derby; Karen A Matthews
Journal: J Clin Lipidol Date: 2016-04-26 Impact factor: 4.766

8. Effects of torcetrapib in patients at high risk for coronary events.

Authors: Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal: N Engl J Med Date: 2007-11-05 Impact factor: 91.245

Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes.

1. High-density lipoprotein cholesterol in diabetes: is higher always better?

2. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Review 3. High-density lipoprotein--the clinical implications of recent studies.

4. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.

5. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

6. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

7. Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression.

8. Effects of torcetrapib in patients at high risk for coronary events.

9. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.

10. High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Review 1. ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?

2. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.

3. Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China.

4. Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status.

5. Combined effects of lifestyle risk factors on fatty liver index.